Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
For in vivo applications where extended half-life is not required, DES(1-3) IGF-1's higher potency allows researchers to achieve equivalent receptor activation at lower administered amounts
In a second round of dual selection, proteases were evolved under a more stringent selection that lowered the amount of available positive selection substrate and increased the concentration of gIII -neg (Extended Data Fig
References WHO | Cardiovascular diseases (CVDs)
Deletion of the IR impaired chondrogenic differentiation, and the effect could not be restored by treatment of insulin, but partially rescued by IGF-1 treatment
US$ 24.51
US$ 29.88
US$ 27.47
US$ 21.52
